Verastem, Inc. Operating Expenses
Verastem, Inc. (VSTM) reported Operating Expenses of $36.34 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-09
- Verastem, Inc. operating expenses for the quarter ending 2019-03-31 was $36.34M, a 75.04% increase year-over-year.
- Verastem, Inc. operating expenses for the quarter ending 2018-12-31 was $35.47M, a 96.48% increase year-over-year.
- Verastem, Inc. operating expenses for the quarter ending 2018-09-30 was $37.08M, a 60.25% increase year-over-year.
- Verastem, Inc. operating expenses for the quarter ending 2018-06-30 was $28.19M, a 109.36% increase year-over-year.
- Verastem, Inc. operating expenses for fiscal 2018 was $121.50M, a 79.19% increase from fiscal 2017.
- Verastem, Inc. operating expenses for fiscal 2017 was $67.80M, a 83.24% increase from fiscal 2016.
- Verastem, Inc. operating expenses for fiscal 2016 was $37.00M, a 36.42% decline from fiscal 2015.
- Verastem, Inc. operating expenses for fiscal 2015 was $58.20M, a 8.57% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 5 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 20 month | Operating Expenses 23 month | Operating Expenses 26 month | Operating Expenses 29 month | Operating Expenses 32 month | Operating Expenses 35 month | Operating Expenses 38 month | Operating Expenses 41 month | Operating Expenses 44 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | $36.34M 10-Q · filed 2019-05-09 | $71.81M derived: sum of 2 quarters · filed 2019-05-09 | $108.89M derived: sum of 3 quarters · filed 2019-05-09 | $137.08M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||
| 2018-12-31 | $35.47M 10-K · filed 2019-03-12 | $72.55M derived: sum of 2 quarters · filed 2019-03-12 | $100.74M derived: sum of 3 quarters · filed 2019-03-12 | $121.50M 10-K · filed 2019-03-12 | ||||||||||
| 2018-09-30 | $37.08M 10-K · filed 2019-03-12 | $65.27M derived: sum of 2 quarters · filed 2019-03-12 | $86.03M 10-Q · filed 2018-11-07 | $104.08M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||
| 2018-06-30 | $28.19M 10-K · filed 2019-03-12 | $48.95M 10-Q · filed 2018-08-08 | $67.01M derived: sum of 3 quarters · filed 2019-05-09 | $90.14M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||
| 2018-03-31 | $20.76M 10-Q · filed 2019-05-09 | $38.81M derived: sum of 2 quarters · filed 2019-05-09 | $61.95M derived: sum of 3 quarters · filed 2019-05-09 | $75.42M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||
| 2017-12-31 | $18.05M 10-K · filed 2019-03-12 | $41.19M derived: sum of 2 quarters · filed 2019-03-12 | $54.66M derived: sum of 3 quarters · filed 2019-03-12 | $67.80M 10-K · filed 2019-03-12 | ||||||||||
| 2017-09-30 | $23.14M 10-K · filed 2019-03-12 | $36.60M derived: sum of 2 quarters · filed 2019-03-12 | $49.75M 10-Q · filed 2018-11-07 | $61.55M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2017-06-30 | $13.47M 10-K · filed 2019-03-12 | $26.61M 10-Q · filed 2018-08-08 | $38.41M derived: sum of 3 quarters · filed 2019-03-12 | $46.47M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2017-03-31 | $13.15M 10-K · filed 2019-03-12 | $24.95M derived: sum of 2 quarters · filed 2019-03-12 | $33.01M derived: sum of 3 quarters · filed 2019-03-12 | $41.72M derived: sum of 4 quarters · filed 2019-03-12 | ||||||||||
| 2016-12-31 | $11.80M 10-K · filed 2018-03-13 | $19.86M derived: sum of 2 quarters · filed 2018-03-13 | $28.57M derived: sum of 3 quarters · filed 2018-03-13 | $37.00M 10-K · filed 2019-03-12 | ||||||||||
| 2016-09-30 | $8.06M 10-K · filed 2018-03-13 | $16.77M derived: sum of 2 quarters · filed 2018-03-13 | $25.20M 10-Q · filed 2017-11-07 | $37.16M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2016-06-30 | $8.71M 10-K · filed 2018-03-13 | $17.14M 10-Q · filed 2017-08-08 | $29.10M derived: sum of 3 quarters · filed 2018-03-13 | $44.64M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2016-03-31 | $8.43M 10-K · filed 2018-03-13 | $20.39M derived: sum of 2 quarters · filed 2018-03-13 | $35.93M derived: sum of 3 quarters · filed 2018-03-13 | $51.39M derived: sum of 4 quarters · filed 2018-03-13 | ||||||||||
| 2015-12-31 | $11.96M 10-K · filed 2017-03-23 | $27.50M derived: sum of 2 quarters · filed 2017-03-23 | $42.96M derived: sum of 3 quarters · filed 2017-03-23 | $58.20M 10-K · filed 2018-03-13 | ||||||||||
| 2015-09-30 | $15.53M 10-K · filed 2017-03-23 | $31.00M derived: sum of 2 quarters · filed 2017-03-23 | $46.24M 10-Q · filed 2016-11-07 | $60.24M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-06-30 | $15.46M 10-K · filed 2017-03-23 | $30.70M 10-Q · filed 2016-08-08 | $44.70M derived: sum of 3 quarters · filed 2017-03-23 | $58.09M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2015-03-31 | $15.24M 10-K · filed 2017-03-23 | $29.24M derived: sum of 2 quarters · filed 2017-03-23 | $42.63M derived: sum of 3 quarters · filed 2017-03-23 | $55.72M derived: sum of 4 quarters · filed 2017-03-23 | ||||||||||
| 2014-12-31 | $14.00M 10-K · filed 2016-03-03 | $27.39M derived: sum of 2 quarters · filed 2016-03-03 | $40.47M derived: sum of 3 quarters · filed 2016-03-03 | $53.61M 10-K · filed 2017-03-23 | ||||||||||
| 2014-09-30 | $13.39M 10-K · filed 2016-03-03 | $26.48M derived: sum of 2 quarters · filed 2016-03-03 | $39.61M 10-Q · filed 2015-11-09 | $51.00M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $13.09M 10-K · filed 2016-03-03 | $26.22M 10-Q · filed 2015-08-10 | $37.61M derived: sum of 3 quarters · filed 2016-03-03 | $48.26M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $13.13M 10-K · filed 2016-03-03 | $24.53M derived: sum of 2 quarters · filed 2016-03-03 | $35.17M derived: sum of 3 quarters · filed 2016-03-03 | $45.45M derived: sum of 4 quarters · filed 2016-03-03 | $101.25M 10-Q · filed 2014-05-08 | |||||||||
| 2013-12-31 | $11.39M 10-K · filed 2015-03-10 | $22.04M derived: sum of 2 quarters · filed 2015-03-10 | $32.32M derived: sum of 3 quarters · filed 2015-03-10 | $41.40M 10-K · filed 2016-03-03 | $88.11M 10-K · filed 2014-03-06 | |||||||||
| 2013-09-30 | $10.64M 10-K · filed 2015-03-10 | $20.93M derived: sum of 2 quarters · filed 2015-03-10 | $30.01M 10-Q · filed 2014-10-30 | $37.98M derived: sum of 4 quarters · filed 2015-03-10 | $76.72M 10-Q · filed 2013-11-12 | |||||||||
| 2013-06-30 | $10.28M 10-K · filed 2015-03-10 | $19.36M 10-Q · filed 2014-08-07 | $27.34M derived: sum of 3 quarters · filed 2015-03-10 | $37.77M derived: sum of 4 quarters · filed 2015-03-10 | $66.08M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $9.08M 10-K · filed 2015-03-10 | $17.06M derived: sum of 2 quarters · filed 2015-03-10 | $27.49M derived: sum of 3 quarters · filed 2015-03-10 | $34.38M derived: sum of 4 quarters · filed 2015-03-10 | $55.79M 10-Q · filed 2013-05-09 | |||||||||
| 2012-12-31 | $7.98M 10-K · filed 2014-03-06 | $18.41M derived: sum of 2 quarters · filed 2014-03-06 | $25.30M derived: sum of 3 quarters · filed 2014-03-06 | $32.23M 10-K · filed 2015-03-10 | $46.71M 10-K · filed 2013-03-26 | |||||||||
| 2012-09-30 | $10.43M 10-K · filed 2014-03-06 | $17.33M derived: sum of 2 quarters · filed 2014-03-06 | $24.25M 10-Q · filed 2013-11-12 | $30.27M derived: sum of 4 quarters · filed 2014-03-06 | $38.74M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $6.90M 10-K · filed 2014-03-06 | $13.82M 10-Q · filed 2013-08-13 | $19.84M derived: sum of 3 quarters · filed 2014-03-06 | $23.89M derived: sum of 4 quarters · filed 2014-03-06 | $28.31M 10-Q · filed 2012-08-13 | |||||||||
| 2012-03-31 | $6.93M 10-K · filed 2014-03-06 | $12.95M derived: sum of 2 quarters · filed 2014-03-06 | $17.00M derived: sum of 3 quarters · filed 2014-03-06 | $19.48M derived: sum of 4 quarters · filed 2014-03-06 | $21.41M 10-Q · filed 2012-05-14 | |||||||||
| 2011-12-31 | $6.02M 10-K · filed 2013-03-26 | $10.07M derived: sum of 2 quarters · filed 2013-03-26 | $12.55M derived: sum of 3 quarters · filed 2013-03-26 | $13.70M 10-K · filed 2014-03-06 | ||||||||||
| 2011-09-30 | $4.05M 10-K · filed 2013-03-26 | $6.53M derived: sum of 2 quarters · filed 2013-03-26 | $7.68M 10-Q · filed 2012-11-13 | |||||||||||
| 2011-06-30 | $2.48M 10-K · filed 2013-03-26 | $3.63M 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-03-31 | $1.15M 10-K · filed 2013-03-26 | |||||||||||||
| 2010-12-31 | $784.00K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |